Carregant...
Transplant biomarkers ready for the clinic?
Biomarkers promise to refine the prediction of allogeneic stem cell transplantation (SCT) outcomes. In this issue of Blood, a phase 3 clinical trial reported by Abu Zaid et al brings us closer to routine biological profiling of major complications that occur after allogeneic SCT.(1)
Guardat en:
| Publicat a: | Blood |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Hematology
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5234226/ https://ncbi.nlm.nih.gov/pubmed/28082289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-11-751842 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|